Results for pharmaceuticals and biotechnology: 349

LONDON, Sept 11 - The existing drugs aren't working, so big pharmaceutical companies are set to step up the hunt for assets to buy in promising fields like biotechnology, as well as non-prescription areas of...

* Half a dose may be enough for immune response * Use of adjuvant could quadruple vaccine supply (Adds details) ZURICH, Nov 17 - A U.S. clinical study suggests that just half a dose of...

* Sees better H2 for pharma services, active ingredients biz * To launch a new plant for the unit in 2011 as demand grows * Shares have more than doubled in 2009, outperforming market BANGALORE,...

* Tax on rich raises most at $460.5 billion over decade * Medical device makers hit with 2.5 percent tax * Worldwide interest relief delayed, raising $26.1 billion * Corporate tax avoiders targeted for $7.5...

* Senators ask why HHS made promises * Vaccine shortage could drive demand (Adds Obama daughters have been vaccinated paragraphs 6-7) WASHINGTON, Oct 27 - The U.S. government may end up throwing away unused doses...

* Glaxo has yet to get FDA approval for vaccine * Senator asked why HHS made promises * Novartis, CSL working to improve production (Adds CDC comment paragraphs 11-13) WASHINGTON, Oct 27 - GlaxoSmithKline has...

* Glaxo has yet to get FDA approval for vaccine * Senator asked why HHS made promises * Novartis, CSL working to improve production WASHINGTON, Oct 27 - GlaxoSmithKline has yet to get U.S. government...

* Vaccine currently approved as two doses in children * Glaxo says 150,000 people have received vaccine so far (Adds further details, background) LONDON, Oct 23 - Britain's GlaxoSmithKline has shown that its H1N1 vaccine...

* Net profit 2.17 bln rupees vs 1.05 bln year ago * CEO says will not comment on Glaxo stake buy reports * Maintains FY2009/10 revenue growth target of 10 percent * Sales in German...

BRUSSELS, Oct 23 - U.S. drugmaker Merck & Co Inc's $41.1 billion takeover of smaller rival Schering-Plough Corp won approval from European Union antitrust regulators on Friday. The takeover, structured by Merck as a reverse...